UBS reiterates Buy on Equifax, maintains $220 target
UBS analyst Kevin Mcveigh has reiterated a Buy rating on Equifax with a $220 price target, while Mizuho analyst Sean Kennedy recently lowered the target to $210 from $222 while maintaining an Outperform rating.

*this image is generated using AI for illustrative purposes only.
UBS analyst Kevin Mcveigh has reiterated a Buy rating on Equifax (NYSE: EFX) while maintaining a price target of $220. This stance contrasts with a recent adjustment by Mizuho, which lowered its target on the credit reporting agency and data analytics firm.
Equifax provides information solutions and human resources outsourcing services. The differing analyst perspectives highlight varying valuation outlooks for the company's near-term performance.
Rating and Target Details
The following table outlines the current ratings and price targets from analysts:
| Firm | Rating | Price Target |
|---|---|---|
| UBS | Buy | $220 |
| Mizuho | Outperform | $210 |
Mizuho analyst Sean Kennedy previously maintained an Outperform rating while lowering the stock's price target to $210 from $222. The adjustment reflected a revised valuation outlook, though the Outperform rating indicated continued confidence in the company's long-term prospects.
What factors could drive a convergence or further divergence between UBS and Mizuho's valuation outlooks?
How might upcoming earnings reports influence the price targets set by these analysts?
What market conditions could impact Equifax's near-term performance despite the Buy ratings?



























